Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion

Gene Therapy

Volumn 4, Issue 11, 1997, Pages 1195-1201

  Suzuki, M ^a   Singh, R N ^a   Crystal, R G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

cAMP; Cystic fibrosis; Epithelial

Indexed keywords

CHLORIDE; COMPLEMENTARY DNA; CYCLIC AMP; FORSKOLIN; GENE PRODUCT; MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADENOVIRUS; ARTICLE; CHIMERA; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY EPITHELIUM;

ADENOVIRIDAE;

EID: 0030829123     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300512     Document Type: Article

References (53)

1. Kerem B et al. Identification of the cystic fibrosis gene: genetic analysis Science 1989; 245: 1073-1080.
2. Riordan JR el al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
3. Rommens JM et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
4. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR et al (eds). Metabolic and Molecular Bases of Inherited Disease. 7th edn. McGraw-Hill: New York, 1995 pp 3799-3876.
5. Riordan JR. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993; 55: 609-630.
6. Welsh MJ et al. Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation. Neuron 1992; 8: 821-829.
7. Sferra TJ, Collins FS. The molecular biology of cystic fibrosis. Annu Rev Med 1993; 44: 133-144.
8. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993; 73: 1251-1254.
9. Drumm ML et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990; 62: 1227-1233.
10. Rich DP et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990; 347: 358-363.
11. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
12. Alton EWFW et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135-142.
13. Engelhardt JF et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther 1993; 4: 759-769.
14. Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993, 90: 10613-10617.
15. Yoshimura K et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer. Nucleic Acids Res 1992; 20: 3233-3240.
16. Zabner J et at. Safety and efficacy of repetitive adenovirusmediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 1994; 6: 75-83.
17. Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
18. Rosenberg M et al. Immunosurvcillance of cystic fibrosis patients undergoing adenovirus-mediated gene transfer. Pediatr Pulmonol Suppl 1996; 13: 271.
19. Flotte TR et al. Fhase I trial of AAV-CFTR gene transfer in adult CF patients with mild disease. Pediatr Pulmonol 1996, 13: 236.
20. Wagner JA et al. Safety of delivery of adeno-associated virus mediated gene transfer of CFTR in the maxillary sinus of CF patients with antrostomies. Pediatr Pulmonol Suppl 1996; 13: 276.
21. Hay JG, McFlvaney NG, Herena J, Crystal RG. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector. Hum Gene Ther 1995; 6: 1487-1496.
22. Zabner J et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmcmbrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J Clin Invest 1996; 97: 1504-1511.
23. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
24. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995; 1: 39-46.
25. Gill DR et al. A phase I clinical trial to assess the safety of DNA/liposome-mediated gene transfer. Pediatr Pulmonol Suppl 1996; 13: 264.
26. Hyde SC et al. Towards DNA/liposome gene therapy for cystic fibrosis: a phase I clinical trial. Pediatr Pulmonol Suppl 1996; 13: 265.
27. Engelhardt JF et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992; 2: 240-248.
28. Jacquot J et al. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 1993; 6: 169-176.
29. Trapnell BC et al. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 1991; 88: 6565-6569.
30. Zabner J, Couture LA, Smith AE, Welsh MJ. Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: efficiency of adenovirus-mediated gene transfer in vitro. Hum Gene Ther 1994; 5: 585-593.
31. Stutts MJ et al. Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J Biol Chem 1993; 268: 20653-20658.
32. Suzuki M, Singh NR, Crystal RG. Regulatable promoters for use in gene therapy applications: modification of the 5′-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be up-regulated by exogenous agents that raise intracellular levels of cAMP. Hum Gen Ther 1996; 7: 1883-1893.
33. Mandel KG, Dharmsathaphorn K, McRoberts JA. Characterization of a cyclic AMP-activated Cl transport pathway in the apical membrane of a human colonie epithelial cell line. J Biol Chem 1986; 261: 704-712.
34. Trapnell BC et al. Down-mgulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J Biol Chem 1991; 266: 10319-10323.
35. Boucher RC et al. Gene therapy for cystic fibrosis using Eldeleted adenovirus: a phase I trial in the nasal cavity. Hum Gene Ther 1994; 5: 615-639.
36. Crystal RG et al A phase I study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. Hum Gene Ther 1995, 6: 643-666.
37. Wilmott RW, Whitsett J, Trapnell B. A phase I study of gene therapy of cystic fibrosis utilizing a replication-deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. Fed Register 1993; 58: 21739.
38. Wilson JM et al. Gene therapy of cystic fibrosis lung disease using El-deleted adenoviruses: a phase I trial. Hum Gene Ther 1994; 5: 501-519.
39. Whitsett JA et al. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nat Genet 1992; 2: 13-20.
40. Widdicombe JH. Cystic fibrosis and β-adrenergic response of airway epithelial cell cultures. Am J Physiol 1986; 251: R818-R822.
41. Breuer W et al. Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells. J Biol Chem 1993; 268: 13935-13939.
42. Rosenfeld MA et al. Increasing expression of the normal human CFTR cDNA in cystic fibrosis epithelial cells results in a progressive increase in the level of cftr protein expression but a limit on the level of camp-stimulated chloride secretion. Hum Gene Ther 1994; 5: 1121-1129.
43. Breuer W, Kartner N, Riordan JR, Cabantchik ZI. Induction of expression of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1992; 267: 10465-10469.
44. Cheng SH et al. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell 1991; 66: 1027-1036.
45. Chneiweiss H, Cordier J, Glowinski J. Cyclic AMP accumulation induces a rapid desensitization of the cyclic AMP-dependent protein kinase in mouse striatal neurons. J Neurochem 1991; 57: 1708-1715.
46. Yoshimura K et al. The cystic fibrosis gene has a 'housekeeping'-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem 1991; 266: 9140-9144.
47. Zeitlin PL et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-sv40 infection. Am J Resp Cell Mol Biol 1991; 4: 313-319
48. Bett AJ, Haddara W, Prevec L, Graham FL. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA 1994; 91: 8802-8806.
49. Graham FL, Van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
50. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
51. Hersh J, Crystal RG, Bewig B. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Therapy 1995; 2: 124-131.
52. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5299.
53. Venglarik CJ, Bridges RJ, Frizzell RA. A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells. Am J Physiol 1990; 259: C358-C364.